U
Acura Pharmaceuticals, Inc. ACUR
$0.05 $0.000.00%
Recommendation
--
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
Weiss Ratings ACUR - OTC PK Click to
Compare
Click to
Compare
Click to
Compare
Rating U
Reward Index Unrated
Risk Index Unrated
Risk Grade U
Reward Grade U
Rating Factors ACUR - OTC PK Click to
Compare
Click to
Compare
Click to
Compare
Dividend Index Unrated
Growth Index Unrated
Efficiency Index Unrated
Solvency Index Unrated
Total Return Index Unrated
Volatility Index Unrated
Beta / Standard Deviation ACUR - OTC PK Click to
Compare
Click to
Compare
Click to
Compare
Beta -2.13
Price History ACUR - OTC PK Click to
Compare
Click to
Compare
Click to
Compare
7-Day Total Return 0.00%
30-Day Total Return 0.00%
60-Day Total Return 150.00%
90-Day Total Return 400.00%
Year to Date Total Return 0.00%
1-Year Total Return -89.58%
2-Year Total Return -77.53%
3-Year Total Return -82.33%
5-Year Total Return -92.88%
52-Week High % Change -90.83%
52-Week Low % Change 24,900.00%
Price ACUR - OTC PK Click to
Compare
Click to
Compare
Click to
Compare
52-Week High Price $0.55
52-Week Low Price $0.00
52-Week Low Price (Date) Jan 17, 2023
52-Week High Price (Date) May 26, 2022
Valuation ACUR - OTC PK Click to
Compare
Click to
Compare
Click to
Compare
Market Cap $3.30M
Enterprise Value 3.54M
Price/Earnings (TTM) --
Earnings Per Share (TTM) -0.03
Earnings Per Share Growth 25.94%
Price/Earnings To Growth --
Price/Sales (TTM) 1.68
Price/Book (Q) 23.81
Enterprise Value/Revenue (TTM) 1.57
Price $0.05
Enterprise Value/EBITDA (TTM) -3.42
Enterprise Value/EBIT -3.19
Market Cap Category Nano Cap
Dividends and Shares ACUR - OTC PK Click to
Compare
Click to
Compare
Click to
Compare
Shares Outstanding 75.561M
Dividend Yield --
Div. Per Share (Most Recent) --
Dividend Per Share (TTM) --
Payout Ratio (TTM) --
Dividend Per Share (Most Recent) --
Company Info ACUR - OTC PK Click to
Compare
Click to
Compare
Click to
Compare
Phone Number 847 705 7709
Address 616 N. North Court Palatine, IL 60067
Website www.acurapharm.com
Country United States
Year Founded 1935
Profitability ACUR - OTC PK Click to
Compare
Click to
Compare
Click to
Compare
Operating Margin (TTM) -49.35%
Profit Margin -51.26%
Management Effectiveness ACUR - OTC PK Click to
Compare
Click to
Compare
Click to
Compare
Return on Assets -38.42%
Return on Equity --
Income Statement ACUR - OTC PK Click to
Compare
Click to
Compare
Click to
Compare
Revenue (TTM) $2.25M
Total Revenue (TTM) $2.25M
Revenue Per Share $0.03
Gross Profit (TTM) $635.00K
EBITDA (TTM) -$1.03M
EBIT (TTM) -$1.11M
Net Income (TTM) -$1.15M
Net Income Avl. to Common (TTM) -$1.15M
Total Revenue Growth (Q YOY) -34.15%
Earnings Growth (Q YOY) 61.36%
EPS Diluted (TTM) -$0.03
EPS Diluted Growth (Q YOY) 83.33%
Balance Sheet ACUR - OTC PK Click to
Compare
Click to
Compare
Click to
Compare
Cash and Short-Term Inv. (Q) $89.00K
Cash Per Share (Q) $0.00
Total Current Assets (Q) $845.00K
Total Preferred Equity (Q) --
Total Equity (Q) $135.00K
Current Ratio (Q) 0.862
Book Value Per Share (Q) $0.00
Total Assets (Q) $1.41M
Total Current Liabilities (Q) $980.00K
Total Debt (Q) $324.00K
Total Liabilities (Q) $1.27M
Total Common Equity (Q) $135.00K
Cash Flow ACUR - OTC PK Click to
Compare
Click to
Compare
Click to
Compare
Cash from Investing (TTM) --
Cash from Financing (TTM) -$8.00K
Net Change in Cash (TTM) -$404.00K
Levered Free Cash Flow (TTM) -$410.60K
Cash from Operations (TTM) -$396.00K
Weiss Ratings